Home Amines 1002-57-9
1002-57-9,MFCD00008245
Catalog No.:AA00015I
1002-57-9 | 8-Aminooctanoic acid
Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$29.00   $20.00
- +
5g
98%
in stock  
$115.00   $80.00
- +
10g
98%
in stock  
$193.00   $135.00
- +
25g
98%
in stock  
$429.00   $300.00
- +
100g
95%
in stock  
$1,355.00   $949.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Q & A
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00015I
Chemical Name:
8-Aminooctanoic acid
CAS Number:
1002-57-9
Molecular Formula:
C8H17NO2
Molecular Weight:
159.2261
MDL Number:
MFCD00008245
IUPAC Name:
8-aminooctanoic acid
InChI:
InChI=1S/C8H17NO2/c9-7-5-3-1-2-4-6-8(10)11/h1-7,9H2,(H,10,11)
InChI Key:
UQXNEWQGGVUVQA-UHFFFAOYSA-N
SMILES:
NCCCCCCCC(=O)O
EC Number:
213-687-9
NSC Number:
59019
Properties
Computed Properties
 
Complexity:
104  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
159.126g/mol
Formal Charge:
0
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
159.229g/mol
Monoisotopic Mass:
159.126g/mol
Rotatable Bond Count:
7  
Topological Polar Surface Area:
63.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-2.6  

Synonyms
 
8-aminooctanoic acid 
omega-AC 
MFCD00008245 
.omega.-Aminocaprylic acid 
UQXNEWQGGVUVQA-UHFFFAOYSA-N 
8-amino capylic acid 
AK-45259 
omega-Aminocaprylic acid, 99+% 
omega-AC 
8AC 
EINECS 213-687-9 
8-Aminocapylic acid 
omega-aminocaprylic acid 
NSC 59019 
PubChem13165 
8-Aminooctanoic acid # 
ACMC-1C3HV 
AC1L24LB 
gamma-AMINOCAPRYLIC ACID 
SCHEMBL35564 
8-Aminooctanoic acid, 99% 
H-AOC(8)-OH 
NH2-(CH2)7-COOH 
8-Aminooctanoic acid 
AC1Q54F8 
CHEMBL196105 
CTK0H9889 
DTXSID00143007 
CHEBI:143265 
NSC59019 
ZINC1689483 
ZX-AT015525 
ANW-47130 
CA-548 
1002-57-9 
LMFA01100059 
NSC-59019 
SBB006735 
AKOS015855191 
CS-W019464 
GS-6649 
MCULE-2737882810 
OR40066 
RTX-012210 
KS-00000M10 
8-Aminocaprylic acid 
AJ-29982 
AN-48239 
BP-13455 
BP-30141 
BR-45259 
CC-23308 
SC-19183 
AX8005512 
ST2406589 
FT-0082174 
omega-Aminocaprylic acid 
FT-0602038 
ST45026869 
X8485 
EN300-96214 
S-1949 
002A579 
C-03935 
I04-1542 
J-000075 
4E709DFA-3A0E-43BB-ABAC-B157B44A07F9 
Octanoic acid, 8-amino- 
8-Aminooctanoic acid, 
omega-aminooctanoic acid 
C8H17NO2 
8-Aminooctanoic acid, 99% 1g 
C8-H17-N-O2 
CID66085 
ACN-046401 
8-Amino caprylic acid 
8-Amino-octanoic acid 
Literature

Title: Stability assessment of a new antithrombotic small peptide, Arg-Gly-Asp-Trp-Arg (RGDWR), and its derivative.

Journal: Biotechnology letters 20170801

Title: In vitro and in vivo evaluation of a 64Cu-labeled NOTA-Bn-SCN-Aoc-bombesin analogue in gastrin-releasing peptide receptor expressing prostate cancer.

Journal: Nuclear medicine and biology 20120701

Title: Bombesin analogues for gastrin-releasing peptide receptor imaging.

Journal: Nuclear medicine and biology 20120501

Title: Determination of caprolactam and 6-aminocaproic acid in human urine using hydrophilic interaction liquid chromatography-tandem mass spectrometry.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120215

Title: Radiolabelled peptides for oncological diagnosis.

Journal: European journal of nuclear medicine and molecular imaging 20120201

Title: Radiosynthesis of a new PSMA targeting ligand ([18F]FPy-DUPA-Pep).

Journal: Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20110701

Title: In vitro and in vivo evaluation of 64Cu-labeled SarAr-bombesin analogs in gastrin-releasing peptide receptor-expressing prostate cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20110301

Title: Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7-14)NH2], in a prostate tumor xenografted mouse model.

Journal: Nuclear medicine and biology 20101001

Title: 3,5-Dicarboxyanilinium nitrate dihydrate.

Journal: Acta crystallographica. Section E, Structure reports online 20100301

Title: NAD+ metabolite levels as a function of vitamins and calorie restriction: evidence for different mechanisms of longevity.

Journal: BMC chemical biology 20100101

Title: In vivo imaging of mesenchymal-epithelial transition factor (c-Met) expression using an optical imaging system.

Journal: Bioconjugate chemistry 20090701

Title: Characterization, biodistribution and small-animal SPECT of I-125-labeled c-Met binding peptide in mice bearing c-Met receptor tyrosine kinase-positive tumor xenografts.

Journal: Nuclear medicine and biology 20090501

Title: Evaluation of the pharmacokinetic effects of various linking group using the 111In-DOTA-X-BBN(7-14)NH2 structural paradigm in a prostate cancer model.

Journal: Bioconjugate chemistry 20080901

Title: A new family of ATP-dependent oligomerization-macrocyclization biocatalysts.

Journal: Nature chemical biology 20071001

Title: Covalent attachment of proteins to solid supports and surfaces via Sortase-mediated ligation.

Journal: PloS one 20070101

Title: Structure-activity relationship study on a simple cationic peptide motif for cellular delivery of antisense peptide nucleic acid.

Journal: Journal of medicinal chemistry 20051020

Title: Application of capillary zone electrophoresis with indirect UV detection to the determination of a model drug, vigabatrin, in dosage forms.

Journal: Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20050803

Title: Peptide inhibitors of alpha-amylase based on tendamistat: development of analogues with omega-amino acids linking critical binding segments.

Journal: Protein and peptide letters 20050401

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Additional Info:
Q & A